Envestnet Asset Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,976
Closed -$241K 4253
2023
Q4
$241K Buy
2,976
+85
+3% +$6.92K ﹤0.01% 3732
2023
Q3
$472K Buy
2,891
+1,844
+176% +$435K ﹤0.01% 3293
2023
Q2
$344K Sell
1,047
-302
-22% -$92.1K ﹤0.01% 3417
2023
Q1
$372K Buy
1,349
+607
+82% +$223K ﹤0.01% 3334
2022
Q4
$288K Sell
742
-140
-16% -$39.5K ﹤0.01% 3454
2022
Q3
$211K Buy
882
+70
+9% +$18.7K ﹤0.01% 3550
2022
Q2
$181K Sell
812
-224
-22% -$96.4K ﹤0.01% 3635
2022
Q1
$706K Buy
1,036
+74
+8% +$44.5K ﹤0.01% 2908
2021
Q4
$665K Buy
+962
New +$711K ﹤0.01% 2894

Other funds holding OM

Envestnet Asset Management's OM Position: Q1 2024 in Review

Envestnet Asset Management sold out of Outset Medical (OM) in Q1 2024, closing a stake of 2,976 shares — an estimated $241K sold.

Envestnet Asset Management first reported a position in OM in Q4 2021 and held it in 9 quarters. The position peaked at $706K in Q1 2022. 114 funds tracked by Wall St. Rank hold OM as of Q1 2024.

  • Envestnet Asset Management reported no remaining Outset Medical position as of Q1 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 2,976 Outset Medical shares in Q1 2024, an estimated $241K.
  • Envestnet Asset Management first reported a position in Outset Medical in Q4 2021 and held it in 9 quarters.
  • Envestnet Asset Management's Outset Medical position peaked at $706K in Q1 2022.
  • 114 funds tracked by Wall St. Rank held Outset Medical as of Q1 2024.

Based on Envestnet Asset Management's 13F filing for Q1 2024, filed 13 May 2024.